A

Agilent Technologies Inc

A, USA

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates through three segments: Life Sciences and Diagnostics Markets, Agilent CrossLab, and Applied Markets. The Life Sciences and Diagnostics Markets segment offers liquid chromatography systems and components; and liquid chromatography mass spectrometry systems. This segment is also involved in the genomics, contract development and manufacturing organization, pathology, companion diagnostics, and biomolecular analysis businesses. The Agilent CrossLab segment provides various services, including repairs, parts, maintenance, installations, training, compliance support, software as a service, asset management, consulting, and other custom services. This segment also offers consumables, including gas chromatography and liquid chromatography columns, sample preparation products, custom chemistries, and various laboratory supplies; software and informatics solutions comprising software for instrument control, data acquisition, data analysis, secure storage of results, and laboratory information and workflow management; and OpenLab laboratory software, an open software platform that enables customers to capture, analyze, and share scientific data throughout the lab and across the enterprise. In addition, it provides automated sample preparation solutions, such as liquid handling, plate management, consumables, and scheduling software. The Applied Markets segment offers products in the areas of gas chromatography, mass spectrometry, spectroscopy, vacuum technology, and remarketed instruments. It markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.

https://www.agilent.com

Stock Price

$0.00

0%

increase compared to yesterday.

Dividend

Frequency:

Quarterly

Rate:

0.255

Next Payout:

Jan 28, 2026

Yield:

0.7414 %
A
stock
A

Want to earn $2 million in the stock market? Here's what you'll need to invest each month. MSN

Read more →
A
stock
A

Want to earn $2 million in the stock market? Here's what you'll need to invest each month. MSN

Read more →

Showing 2 of 10

Analyst Ratings & Sentiment

(Last Updated 2025-10-31)

Rating:

BUY

Target Price:

$169.6667

Analyst Picks

Strong Buy

9

Buy

2

Hold

9

Sell

0

Strong Sell

0

Sentiment:

Bullish

Finn Analysis

(Last Updated 2025-10-31)

Health Score

Price to Earnings Ratio (P/E)

-

Medium

29.79

Low ≥ 50

High ≤ 10

Price to Book Ratio (P/B)

-

Very High

5.80

Low ≤ 1

High ≥ 3

Return on Equity (ROE)

-

Very Low

6.44 %

Low ≤ 5%

High ≥ 25%

Return on Assets (ROA)

-

Very Low

3.41 %

Low ≤ 2%

High ≥ 10%

Free Cash Flow - Revenue % (FCF)

-

Very High

24.29 %

Low ≤ 5%

High ≥ 15%

Debt to Equity

-

Very Low

0.89

Low ≥ 1

High ≤ 0.3

Investors

* Institutions hold a combined 24.28% of the total shares of Agilent Technologies Inc

1.

Vanguard Total Stock Mkt Idx Inv

(3.1599%)

since

2025/07/31

2.

Vanguard 500 Index Investor

(2.4888%)

since

2025/07/31

3.

Vanguard Mid Cap Index Institutional

(2.2433%)

since

2025/07/31

4.

T. Rowe Price US Mid-Cap Growth Equity

(1.3653%)

since

2025/06/30

5.

T. Rowe Price Mid-Cap Growth

(1.3628%)

since

2025/07/31

6.

Fidelity 500 Index

(1.2748%)

since

2025/07/31

7.

SPDR® S&P 500® ETF

(1.216%)

since

2025/08/31

8.

iShares Core S&P 500 ETF

(1.21%)

since

2025/08/31

9.

Vanguard Health Care Inv

(1.171%)

since

2025/06/30

10.

VanEck Morningstar Wide Moat

(0.8993%)

since

2025/06/30

11.

Vanguard Value Index Inv

(0.8913%)

since

2025/07/31

12.

VanEck Morningstar Wide Moat ETF

(0.8645%)

since

2025/08/30

13.

Vanguard Mid-Cap Growth ETF

(0.8399%)

since

2025/07/31

14.

Impax Leaders Strategy Composite

(0.7886%)

since

2025/07/31

15.

MFS International Intrinsic Value A

(0.7877%)

since

2025/07/31

16.

The Health Care Select Sector SPDR® ETF

(0.6867%)

since

2025/08/31

17.

MFS Large Cap Growth Equity

(0.6614%)

since

2025/06/30

18.

MFS Massachusetts Inv Gr Stk A

(0.6516%)

since

2025/07/31

19.

Pictet-Water I EUR

(0.639%)

since

2025/05/31

20.

DWS Vermögensbildungsfonds I LD

(0.6173%)

since

2025/07/31

21.

Balyasny Asset Management LLC

(0.4569%)

since

2025/06/30

* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.

Earnings History

EPS ActualEPS EstimateEPS DifferenceSurprise Percent

Upcoming Earnings Release

Date

2026-01-31

EPS Estimate

1.42

Latest Release

Date

2025-10-31

EPS Actual

1.59

EPS Estimate

1.58

EPS Difference

0.01

Surprise Percent

0.6329%

Investing Fit Scorecard

(Last Updated 2025-10-31)

Deep Value
Potential Value Candidate(4.5)
Defensive
Highly Defensive(8.5)
Dividend
Decent Dividend Payer(4)
Economic Moat
Wide Moat Company(8.3)
GARP
Fair GARP(6)
Growth
Moderate Growth(5)
Momentum
Moderate Momentum(4)
Net Net
Not Undervalued (Net-Net)(2.5)
Quality
High Quality(8)
Value
Fair Value(4.5)

Income Statement

(Last Updated 2025-10-31)

Revenue

$ 0

Cost Of Revenue

$ 0

Gross Profit

$ 0

Operating Expenses

$ 0

Operating Income

$ 0

Interest Expense

$ 0

Pretax Income

$ 0

Net Income

$ 0

Income Tax Expense

$ 0

EBITDA

$ 0

Total Other Income Expense Net

$ 0

Earnings Per Share

0

Dividends Per Share

0

Shares Outstanding

0

Operating Margin

0%

Trend

Balance Sheet

(Last Updated 2025-10-31)

Cash

$ 0

Short Term Investments

$ 0

Receivables

$ 0

Inventories

$ 0

Total Current Assets

$ 0

Property Plant Equipment

$ 0

Total Assets

$ 0

Payables

$ 0

Short Term Debt

$ 0

Long Term Debt

$ 0

Total Liabilities

$ 0

Equity

$ 0

Trend

Cash Flow

(Last Updated 2025-10-31)

Net Income

$ 0

Depreciation

$ 0

Change In Working Capital

$ 0

Cash From Operations

$ 0

Capital Expenditures

$ 0

Cash From Investing

$ 0

Cash From Financing

$ 0

Net Change In Cash

$ 0

Trend

Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.